Betz Stephen F.'s Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Sep 6, 2022
- Accession no.
- 0001209191-22-048734
- Filed
- Sep 6, 2022
- Trade date
- May 20-Sep 1, 2022
- Filing delay
- 109 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $58.1K. It was filed 109 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Betz Stephen F.CIK 0001886575 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | Common Stock | JOtherAcquired | +1,336 | $11.02 | +$14,722.72 | 108,934 | Direct | |
| Sep 1, 2022 | Common Stock | SSaleDisposed | −3,126 | $18.59 | −$58,112.34 | 105,808 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.